| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3991997 | Journal of Thoracic Oncology | 2010 | 7 Pages |
Abstract
Single-dose intrapleural administration of doxetaxel is well tolerated in patients with MPE with minimal toxicity. The excellent clinical responses in this study after treatment with intrapleural doxetaxel suggest that further investigation is warranted.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David R. MD, Matthew D. MD, Gina R. PhD, Jianfen MS, Sandra G. BSN, Thomas M. MD, Heidi H. MD,